Some links on our site may earn us a commission at no extra cost to you. Learn more.
Medical Disclaimer: We are not doctors or medical professionals, and nothing on this page is medical advice. This article is for general informational purposes only. GLP-1 medications are prescription drugs that require evaluation by a licensed healthcare provider, and they are not appropriate for everyone. Always consult a qualified clinician before starting, stopping, or changing any medication or weight loss program.
SkinnyRx has carved out a distinctive spot in the crowded GLP-1 telehealth market with one genuine differentiator: medication formats. While most platforms offer injectable compounded semaglutide and nothing else, SkinnyRx’s published lineup spans injections, sublingual drops, and oral tablets — for both semaglutide and tirzepatide. That variety, a strong Trustpilot record, and aggressive pricing make it worth a serious look. So does its fine print, and one regulatory event you should know about before enrolling. Here’s the full picture.
What SkinnyRx is
SkinnyRx is a direct-to-consumer telehealth platform operated by Lean Rx, Inc. of Sacramento, California. Like its competitors, it follows the standard three-entity model: the platform provides the technology and coordination, independent licensed clinicians make the medical decisions, and state-licensed 503A compounding pharmacies prepare and ship the medication. Per the company’s own terms, SkinnyRx itself is not a healthcare provider. The process is fully online and mostly asynchronous — intake forms and in-app messaging, with a live video consult only where state law requires it, and lab work optional rather than mandatory.
The format menu — SkinnyRx’s real differentiator
According to the company’s published materials, the lineup includes:
- Compounded injectable semaglutide — the standard once-weekly injection
- Compounded sublingual semaglutide — a once-daily liquid dissolved under the tongue
- Compounded semaglutide tablets — a once-daily oral option
- Compounded injectable tirzepatide — the dual GIP/GLP-1 class
- Compounded tirzepatide tablets — rare in this market; SkinnyRx is one of very few offering it
For the meaningful share of people who won’t start GLP-1 treatment because of needles, non-injection formats remove the barrier entirely. One evidence note worth carrying into your clinician conversation: published research to date has generally shown stronger results for injectable formulations than oral/sublingual compounded routes — a trade-off between format comfort and the strength of the evidence behind it.
Pricing
Published pricing as of mid-2026 starts around $199/month for injectable or sublingual compounded semaglutide and roughly $299/month for tirzepatide options, with consultations bundled in, no separate membership fee for compounded plans, free overnight shipping, and FSA/HSA cards accepted (insurance is not). Entry prices can dip lower on longer commitments and promotional tiers. Which brings us to the fine print.
Prices are approximate, current as of publication, and change frequently — confirm the latest price with the retailer before buying.
The fine print: bundles and refunds
The most consistent complaint pattern in SkinnyRx’s independent reviews concerns multi-month bundle billing — customers who believed they were signing up month-to-month and were charged for large prepaid bundles upfront, sometimes several thousand dollars. Add a no-refund-once-shipped policy and a cancellation process that reviewers describe as requiring a phone call, and the lesson is clear: read the checkout page like a contract, confirm exactly what’s being charged today, and screenshot it. The company’s Trustpilot standing is genuinely strong — roughly 4.8 stars across 4,000+ reviews with active response to complaints — while its BBB profile tells the rougher story, which is exactly why we recommend reading both before any telehealth enrollment.
The FDA warning letter — what it was and wasn’t
In February 2026, the FDA issued a warning letter to Lean Rx, Inc. (dba SkinnyRx) over marketing and labeling language for its compounded semaglutide and tirzepatide products — part of a broad enforcement sweep that reportedly covered dozens of telehealth companies the same day. The agency’s objection was to claims it considered false or misleading (notably “same active ingredient”-style equivalence language), not to manufacturing safety or pharmacy contamination. Two takeaways for you as a consumer: first, it’s a material compliance event worth knowing about; second, it underlines the industry-wide truth we repeat in every review — compounded medications are not FDA-approved products, have not been reviewed by the FDA for safety, effectiveness, or quality as finished formulations, and are not generic equivalents of Wegovy®, Ozempic®, Zepbound®, or Mounjaro®. Any platform’s marketing that blurs that line is marketing to be skeptical of.
Who SkinnyRx fits
A good fit if: needles are the thing standing between you and treatment your clinician recommends — the sublingual and tablet formats are this platform’s genuine reason to exist; you’re a cash-pay shopper comfortable with the compounded trade-off; and you’re disciplined about reading billing terms.
Look elsewhere if: you want FDA-approved brand-name medication (see our Hims review for the leading brand-name route); you want clinical depth, labs, and coaching; or prepaid bundles and phone-call cancellations are dealbreakers on principle — in which case month-to-month programs like TrimRX (our review) are the cleaner structure.
Bottom line
SkinnyRx earns its place in the comparison set on format variety no one else matches and competitive headline pricing, and it loses points on billing opacity and a marketing-claims warning letter that demands informed skepticism. If a non-injectable compounded GLP-1 is what you and your licensed healthcare provider land on, SkinnyRx belongs on the shortlist — enrolled with your eyes open, the checkout page screenshotted, and the recurring price confirmed in writing.
Program details, pricing, and terms described here are based on publicly available information as of mid-2026 and change frequently — verify everything on the provider’s official website. Ozempic®, Wegovy®, Zepbound®, and Mounjaro® are trademarks of their respective owners, which are not affiliated with this site.
